AIM ImmunoTech Announces Clinical Trial Agreement for a Phase 2a Human Challenge Trial of Ampligen as a Potential Intranasal Prophylaxis Against Respiratory Viruses

Amy Giles
Increasing Engagement

Liz Kane
Impactful Strategy

Matthew Durham
Omnidynamic Marketing

Bud Bilanich
Success Coach

Frank Burrell
Scientific Storytelling

Joey Cohen
Medication Adherence

Pat Purcell
Meeting Engagement

Daniel Sontupe
Market Access

Suma Ramadas, PhD
Medical Affairs

Stacey Gandler
Brand Nourishment

Paul Theisen
Patient Acquisition

Matt Turner
Patient Affordability

David Linetsky
Point-of-Care Marketing

Brenda Snow
Authentic Patient Voice